1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
  4. > Renal Failure Global Clinical Trials Review, H2, 2015

Renal Failure Global Clinical Trials Review, H2, 2015

  • September 2015
  • -
  • Global Data
  • -
  • 135 pages

Renal Failure Global Clinical Trials Review, H2, 2015

Summary

GlobalData's clinical trial report, “Renal Failure Global Clinical Trials Review, H2, 2015" provides an overview of Renal Failure clinical trials scenario. This report provides top line data relating to the clinical trials on Renal Failure. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table Of Contents

Renal Failure Global Clinical Trials Review, H2, 2015
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Renal Failure 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Renal Failure to Genito Urinary System And Sex Hormones Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Renal Failure to Genito Urinary System And Sex Hormones Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Renal Failure 25
Subjects Recruited Over a Period of Time 46
Clinical Trials by Sponsor Type 47
Prominent Sponsors 48
Top Companies Participating in Renal Failure Therapeutics Clinical Trials 49
Prominent Drugs 50
Clinical Trial Profiles 51
Clinical Trial Overview of Top Companies 51
Amgen Inc. 51
Clinical Trial Overview of Amgen Inc. 51
Sanofi 55
Clinical Trial Overview of Sanofi 55
Novartis AG 59
Clinical Trial Overview of Novartis AG 59
F. Hoffmann-La Roche Ltd. 63
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 63
AbbVie Inc. 67
Clinical Trial Overview of AbbVie Inc. 67
Pfizer Inc. 71
Clinical Trial Overview of Pfizer Inc. 71
Astellas Pharma Inc. 74
Clinical Trial Overview of Astellas Pharma Inc. 74
AstraZeneca Plc 76
Clinical Trial Overview of AstraZeneca Plc 76
Shire Plc 78
Clinical Trial Overview of Shire Plc 78
Abbott Laboratories 80
Clinical Trial Overview of Abbott Laboratories 80
Clinical Trial Overview of Top Institutes / Government 82
Austin Health 82
Clinical Trial Overview of Austin Health 82
Vanderbilt University 83
Clinical Trial Overview of Vanderbilt University 83
Shiraz University of Medical Sciences 85
Clinical Trial Overview of Shiraz University of Medical Sciences 85
The National Institute of Diabetes and Digestive and Kidney Diseases 86
Clinical Trial Overview of The National Institute of Diabetes and Digestive and Kidney Diseases 86
Seoul National University Hospital 88
Clinical Trial Overview of Seoul National University Hospital 88
Tehran University of Medical Sciences 89
Clinical Trial Overview of Tehran University of Medical Sciences 89
Isfahan University of Medical Sciences 91
Clinical Trial Overview of Isfahan University of Medical Sciences 91
Tabriz University of Medical Sciences 92
Clinical Trial Overview of Tabriz University of Medical Sciences 92
Yonsei University 93
Clinical Trial Overview of Yonsei University 93
Medical University of Vienna 95
Clinical Trial Overview of Medical University of Vienna 95
Five Key Clinical Profiles 96
Appendix 132
Abbreviations 132
Definitions 132
Research Methodology 133
Secondary Research 133
About GlobalData 134
Contact Us 134
Disclaimer 134
Source 135

List of Tables
Renal Failure Therapeutics, Global, Clinical Trials by Region, 2015* 7
Renal Failure Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Renal Failure Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Renal Failure Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10
Renal Failure Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Renal Failure Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Renal Failure Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2015* 13
Renal Failure Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2015* 14
Proportion of Renal Failure to Genito Urinary System And Sex Hormones Clinical Trials, G7 Countries (%), 2015* 15
Renal Failure Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Renal Failure Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Renal Failure to Genito Urinary System And Sex Hormones Clinical Trials, E7 Countries (%), 2015* 18
Renal Failure Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Renal Failure Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Renal Failure Therapeutics, Global, Clinical Trials by Phase, 2015* 21
Renal Failure Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22
Renal Failure Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Renal Failure Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Renal Failure Therapeutics, Global, Suspended Clinical Trials, 2015* 25
Renal Failure Therapeutics, Global, Withdrawn Clinical Trials, 2015* 26
Renal Failure Therapeutics, Global, Terminated Clinical Trials, 2015* 33
Renal Failure Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 46
Renal Failure Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 47
Renal Failure Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 48
Renal Failure Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 49
Renal Failure Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 50
Renal Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2015* 51
Renal Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2015* 55
Renal Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015* 59
Renal Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2015* 63
Renal Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by AbbVie Inc., 2015* 67
Renal Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015* 71
Renal Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Astellas Pharma Inc., 2015* 74
Renal Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca Plc, 2015* 76
Renal Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Shire Plc, 2015* 78
Renal Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Abbott Laboratories, 2015* 80
Renal Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Austin Health, 2015* 82
Renal Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Vanderbilt University, 2015* 83
Renal Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Shiraz University of Medical Sciences, 2015* 85
Renal Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Diabetes and Digestive and Kidney Diseases, 2015* 86
Renal Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Seoul National University Hospital, 2015* 88
Renal Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Tehran University of Medical Sciences, 2015* 89
Renal Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Isfahan University of Medical Sciences, 2015* 91
Renal Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Tabriz University of Medical Sciences, 2015* 92
Renal Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Yonsei University, 2015* 93
Renal Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Vienna, 2015* 95

List of Figures
Renal Failure Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Renal Failure Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Renal Failure Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Renal Failure Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10
Renal Failure Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Renal Failure Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
Renal Failure Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2015* 13
Renal Failure Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2015* 14
Proportion of Renal Failure to Genito Urinary System And Sex Hormones Clinical Trials, G7 Countries (%), 2015* 15
Renal Failure Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Renal Failure Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Renal Failure to Genito Urinary System And Sex Hormones Clinical Trials, E7 Countries (%), 2015* 18
Renal Failure Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Renal Failure Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Renal Failure Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21
Renal Failure Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22
Renal Failure Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Renal Failure Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Renal Failure Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 46
Renal Failure Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 47
Renal Failure Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 48
Renal Failure Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 49
Renal Failure Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 50
GlobalData Methodology 133

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Proteinuria Treatment Market: By Type (Angiotensin Converting Enzyme (ACE) Inhibitors, Aldosterone Antagonist (i.e., spironolactone), Angiotensin Receptor Blocker (ARB), and Others) & By Region-Forecast (2016-2021)

Proteinuria Treatment Market: By Type (Angiotensin Converting Enzyme (ACE) Inhibitors, Aldosterone Antagonist (i.e., spironolactone), Angiotensin Receptor Blocker (ARB), and Others) & By Region-Forecast (2016-2021)

  • $ 5250
  • Industry report
  • August 2016
  • by Industry ARC

Proteinuria is a result of an excess of serum proteins in the urine, which can led to renal damage. The most common cause of proteinuria is diabetes. Globally, development the arena of proteomics and ...

Benign prostatic hyperplasia (BPH)- Market Insights, Epidemiology and Market Forecast-2023

Benign prostatic hyperplasia (BPH)- Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • November 2016
  • by Delve Insight

Note*: This report requires 5 business days to complete. DelveInsight’s Benign prostatic hyperplasia (BPH) - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of ...

Endometriosis- Market Insights, Epidemiology and Market Forecast-2023

Endometriosis- Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • November 2016
  • by Delve Insight

Note*: This report requires 5 business days to complete. DelveInsight’s Endometriosis - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global ...

Global Endometriosis Industry

October 2016 $ 4950

ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.